| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2018-11-09 |
详情>>
股本变动：
变动后总股本24803.73万股
变动原因 ▼▲
- 原因：
- from December 31, 2017 to September 30, 2018
Common stock issued in connection with exercise of stock options
|
| 2018-11-09 |
详情>>
业绩披露：
2018年三季报(累计)每股收益-0.41美元,归母净利润-1亿美元,同比去年增长46.45%
|
| 2018-11-08 |
财报披露：
美东时间 2018-11-08 盘后发布财报
|
| 2018-08-08 |
详情>>
业绩披露：
2018年中报每股收益-0.27美元,归母净利润-6579.5万美元,同比去年增长52.49%
|
| 2018-07-04 |
详情>>
内部人交易：
BRANCACCIO JOHN P共交易2笔
|
| 2018-05-10 |
财报披露：
美东时间 2018-05-10 盘后发布财报
|
| 2018-05-10 |
详情>>
业绩披露：
2018年一季报每股收益-0.15美元,归母净利润-3610.4万美元,同比去年增长44.11%
|
| 2018-04-20 |
股东大会：
将于2018-06-12召开股东大会
会议内容 ▼▲
- 1.To elect seven (7) members to our Board of Directors;
2.To hold an advisory vote on executive compensation;
3.To approve a three-year frequency for holding an advisory vote on executive compensation;
4.To ratify the appointment of BDO USA, LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2018;
5.To amend our Second Amended and Restated Certificate of Incorporation, as amended, to increase the number of shares of common stock authorized for issuance from 400,000,000 to 500,000,000;
6.To amend our 2017 Equity Incentive Plan to increase the number of shares approved from 9,000,000 to 19,400,000;
7.To transact such other matters as may properly come before the Annual Meeting and any adjournment or postponement thereof.
|
| 2018-03-01 |
财报披露：
美东时间 2018-03-01 盘后发布财报
|
| 2018-03-01 |
详情>>
业绩披露：
2015年年报每股收益-1.11美元,归母净利润-1.18亿美元,同比去年增长-22.77%
|
| 2018-03-01 |
详情>>
业绩披露：
2017年年报每股收益-1美元,归母净利润-2.24亿美元,同比去年增长-12.96%
|
| 2017-11-09 |
财报披露：
美东时间 2017-11-09 盘后发布财报
|
| 2017-11-09 |
详情>>
业绩披露：
2017年三季报(累计)每股收益-0.84美元,归母净利润-1.87亿美元,同比去年增长-35.05%
|
| 2017-08-09 |
详情>>
业绩披露：
2017年中报每股收益-0.63美元,归母净利润-1.38亿美元,同比去年增长-40.61%
|
| 2017-08-09 |
详情>>
业绩披露：
2016年中报每股收益-0.69美元,归母净利润-9849.7万美元,同比去年增长-61.32%
|
| 2017-05-10 |
详情>>
业绩披露：
2017年一季报每股收益-0.3美元,归母净利润-6460.4万美元,同比去年增长-7.78%
|
| 2017-04-28 |
股东大会：
将于2017-06-27召开股东大会
会议内容 ▼▲
- 1.To elect seven (7) members to our Board of Directors;
2.To amend our Second Amended and Restated Certificate of Incorporation, as amended, to increase the number of shares of common stock authorized for issuance from 350,000,000 to 400,000,000;
3.To approve the Synergy Pharmaceuticals Inc. 2017 Equity Incentive Plan;
4.To ratify the appointment of BDO USA, LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2017;
5.To transact such other matters as may properly come before the Annual Meeting and any adjournment or postponement thereof.
|
| 2017-03-01 |
详情>>
业绩披露：
2016年年报每股收益-1.21美元,归母净利润-1.99亿美元,同比去年增长-69.03%
|
| 2016-12-23 |
复牌提示：
2016-12-22 16:25:40 停牌，复牌日期 2016-12-22 17:00:00
|
| 2016-11-09 |
详情>>
业绩披露：
2016年三季报(累计)每股收益-0.89美元,归母净利润-1.39亿美元,同比去年增长-59.37%
|
| 2016-04-20 |
股东大会：
将于2016-06-07召开股东大会
会议内容 ▼▲
- 1.To elect seven (7) members to our Board of Directors;
2. To ratify the appointment of BDO USA, LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2016;
3.To approve, on an advisory basis, the compensation of the Company’s named executive officers;
4.To transact such other matters as may properly come before the Annual Meeting and any adjournment or postponement thereof.
|
| 2015-04-14 |
股东大会：
将于2015-06-08召开股东大会
会议内容 ▼▲
- 1. To re-elect (6) current directors whose terms will continue until the 2016 Annual Meeting of Stockholders;
2. To amend our Second Amended and Restated Certificate of Incorporation, as amended, to increase the number of shares of common stock authorized for issuance from 200,000,000 to 350,000,000;
3. To amend our 2008 Equity Compensation Incentive Plan, as amended, to increase the number of shares of our common stock reserved for issuance from 15,000,000 to 30,000,000;
4. To ratify the appointment by the Audit Committee of the Board of Directors of BDO USA, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2015;
5. To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2014-09-16 |
股东大会：
将于2014-11-03召开股东大会
会议内容 ▼▲
- 1.To re-elect (6) current Synergy directors whose terms will continue until the 2015 Annual Meeting of Stockholders;
2.To ratify the appointment by the Audit Committee of the Board of Directors of BDO USA, LLP as the independent registered public accounting firm of Synergy Pharmaceuticals Inc. for its fiscal year ending December 31, 2014;
3.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2013-08-30 |
股东大会：
将于2013-09-30召开股东大会
会议内容 ▼▲
- 1. To re-elect (6) current Synergy directors whose terms will continue until the 2014 Annual Meeting of Stockholders;
2. To ratify the appointment by the Audit Committee of the Board of Directors of BDO USA, LLP as the independent registered public accounting firm of Synergy Pharmaceuticals Inc. for its fiscal year ending December 31, 2013;
3. To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|